CAS NO: | 2640366-38-5 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | FTO-IN-8 (FTO-43) is a N6-methyladenosine demethylase (FTO) (fat mass- and obesity-associated protein) inhibitor with theIC50value of 5.5 μM. FTO-IN-8 has anti-cancer cell proliferative activity[1]. | ||||||||||||||||
体外研究 (In Vitro) | FTO-IN-8 (FTO-43) (0-50 μM, 24-72 h) inhibits the proliferation of cancer cells with no cytotoxicity to normal colonic cells[1]. Cell Viability Assay[1]
| ||||||||||||||||
分子量 | 346.85 | ||||||||||||||||
性状 | Oil | ||||||||||||||||
Formula | C19H23ClN2O2 | ||||||||||||||||
CAS 号 | 2640366-38-5 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(288.31 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |